|
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
RECRUITINGSponsored by University Hospital, Toulouse
Actively Recruiting
SponsorUniversity Hospital, Toulouse
Started2024-05-06
Est. completion2029-04
Eligibility
Age6 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06387654
Summary
The aim of this project is to start a biological and clinical collection of patients presenting autoimmune, dysimmune or auto-inflammatory dermatological diseases. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies.
Eligibility
Age: 6 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria: Skin damage of documented or probable autoimmune, dysimmune or autoinflammatory origin. The patients included may be adults or children, and will be: * Patients with autoimmune bullous dermatoses (pemphigus, pemphigoid and others), * Patients with systemic autoimmune diseases associated with skin damage (lupus, scleroderma, dermatomyositis for example), * Patients with cutaneous lupus * Patients with dysimmune skin diseases (psoriasis, eczema) * Patients with immuno-induced dermatological disorders or drug dermatitis * Patients receiving, or likely to receive, new, innovative therapies (new molecule on the market, checkpoint inhibitors, gene therapy, cell therapy, etc.). Patients with dermatological damage whose autoimmune, dysimmune or auto-inflammatory origin is suspected Exclusion Criteria: * Patients under protective supervision (guardianship, curators) * Patients under 6 years old * Pregnant or breastfeeding woman
Conditions5
Auto-inflammatory Dermatological DiseasesAutoimmune Bullous DermatosisDysimmune Dermatological DiseasesLupusSkin Diseases
Interventions2
Related trials
- Analysis of Circulating Tumor Markers in Blood — Institut du Cancer de Montpellier - Val d'Aurelle
- B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. — Poitiers University Hospital
- Biobank for Inflammatory Chronic Diseases and Osteoporosis — University Hospital, Toulouse
- Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. — Hospices Civils de Lyon
- Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis — Assistance Publique - Hôpitaux de Paris
- Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer — Hospices Civils de Lyon
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases — University Hospital, Toulouse
- DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls — Centre Hospitalier Universitaire Dijon
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUniversity Hospital, Toulouse
Started2024-05-06
Est. completion2029-04
Eligibility
Age6 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06387654